Nomura Downgrades Pharmacyclics To Neutral By: Benzinga via Benzinga March 06, 2015 at 07:50 AM EST Analysts at Nomura downgraded Pharmacyclics Inc. (NASDAQ: PCYC) from Buy to Neutral. The price target for Pharmacyclics has been ... Read More >>